## Monoclonal antibody Anti Leu 7 has been used to enumerate peripheral blood N K cells in 20 renal allograft recipients. Blood was taken preoperatively and three times per week for the first month a f e r transplantation; separated mononuclear cells were stained with Anti Leu 7 then analysed on a
Are “natural killer” cells involved in allograft rejection?
✍ Scribed by Arto Nemlander; Eero Saksela; Pekka Häyry
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 335 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Natural killer" (NK) effector cells and large granular lymphocytes (LGL) are found inside rat renal allografts during rejection. Their appearance in situ precedes the appearance of cytotoxic T lymphocytes, and concomitantly with their influx in the allograft, the NK activity and the LGL are depleted from the recipient spleen. This suggests that the NK effector cells and the LGL are involved in allograft rejection, although their role(s) among the other in situ inflammatory effector pathways remains to be clarified.
📜 SIMILAR VOLUMES
## Abstract ## Objective To investigate the role of invariant natural killer T (iNKT) cells in TNF^__ΔARE/+__^ mice, an animal model of spondylarthritis (SpA) with both gut and joint inflammation. ## Methods The frequency and activation of iNKT cells were analyzed on mononuclear cells from the l
## Abstract Natural cell‐mediated cytotoxicity (NCMC), measured against a variety of tumors, is mediated by at least two sub‐populations of effector cells: natural cytotoxic (NC) and natural killer (NK). The studies described in this report show that target lysis by NC cells requires a prolonged (1
## Abstract We previously reported that natural killer (NK) cells that had infiltrated renal‐cell carcinoma (RCC) proliferated vigorously in culture with interleukin‐2 (IL‐2) and lysed autologous tumor cells. In this study, we investigate the susceptibility of RCC cells to NK‐cell lysis and their a
Focal rejection involves less than 20% of portal tracts in liver allograft biopsy results. The clinical significance of "focal" rejection on protocol liver biopsy results is unknown. The purpose of this study was to prospectively determine the incidence of clinically significant rejection in patient